1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Primitive Neuroectodermal Tumor: new trials by email Literature Review of Primitive Neuroectodermal Tumor trials Research Report on Primitive Neuroectodermal Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors Antineoplaston therapy (Atengenal + Astugenal) - Primitive Neuroectodermal Tumor | Phase 2 | Terminated | Burzynski Research Institute | 1 | 1996-12-12 | 2017-09-29 |
Neuroectodermal Tumors, Primitive (1)
Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1) · Neuroectodermal Tumors (1)
antineoplaston A10 (1) · antineoplaston AS 2-1 (1)
Burzynski Research Institute (1)
United States (1)